Feedback / Questions
pembrolizumab biosimilar (GME751) - Sandoz
pembrolizumab biosimilar (QL2107) - Qilu Pharma
emavusertib (CA-4948) - Curis, Dr. Reddy’s
Keytruda (pembrolizumab) - Merck (MSD)
http://clinicaltrials.gov/ct2/show/NCT06439836
Aug 7, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next